MX9301732A - Derivados de chitosan n-substituidos, procedimiento para su preparacion y uso de los mismos. - Google Patents

Derivados de chitosan n-substituidos, procedimiento para su preparacion y uso de los mismos.

Info

Publication number
MX9301732A
MX9301732A MX9301732A MX9301732A MX9301732A MX 9301732 A MX9301732 A MX 9301732A MX 9301732 A MX9301732 A MX 9301732A MX 9301732 A MX9301732 A MX 9301732A MX 9301732 A MX9301732 A MX 9301732A
Authority
MX
Mexico
Prior art keywords
structural elements
alkyl
co2h
alkoxy
chitosan
Prior art date
Application number
MX9301732A
Other languages
English (en)
Spanish (es)
Inventor
Dieter Lohmann
Donald Richard Randell
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of MX9301732A publication Critical patent/MX9301732A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/736—Chitin; Chitosan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J5/00—Manufacture of articles or shaped materials containing macromolecular substances
    • C08J5/18—Manufacture of films or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C08J2305/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Manufacturing & Machinery (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Cosmetics (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
MX9301732A 1992-03-27 1993-03-26 Derivados de chitosan n-substituidos, procedimiento para su preparacion y uso de los mismos. MX9301732A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH98192 1992-03-27

Publications (1)

Publication Number Publication Date
MX9301732A true MX9301732A (es) 1994-01-31

Family

ID=4199699

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9301732A MX9301732A (es) 1992-03-27 1993-03-26 Derivados de chitosan n-substituidos, procedimiento para su preparacion y uso de los mismos.

Country Status (9)

Country Link
EP (1) EP0563013B1 (cg-RX-API-DMAC10.html)
JP (1) JPH0641202A (cg-RX-API-DMAC10.html)
KR (1) KR100257092B1 (cg-RX-API-DMAC10.html)
AT (1) ATE152132T1 (cg-RX-API-DMAC10.html)
AU (1) AU658986B2 (cg-RX-API-DMAC10.html)
BR (1) BR9301334A (cg-RX-API-DMAC10.html)
CA (1) CA2092513A1 (cg-RX-API-DMAC10.html)
DE (1) DE59306229D1 (cg-RX-API-DMAC10.html)
MX (1) MX9301732A (cg-RX-API-DMAC10.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59409748D1 (de) * 1993-06-11 2001-06-21 Ciba Sc Holding Ag Bleichhilfsmittel
US5863518A (en) * 1994-10-21 1999-01-26 Nihon Medi-Physics Co., Ltd. Diagnostic imaging agent with backbone with modified sugar chain end
ES2127499T3 (es) * 1994-11-24 1999-04-16 Ciba Geigy Ag Quitosanos fosfonometilados.
EP0718313B1 (de) * 1994-12-22 2000-10-11 Ciba SC Holding AG N-cyanomethylierte Chitosane und deren Hydrolyseprodukte
KR100348804B1 (ko) * 1998-12-07 2002-11-18 주식회사 태평양 키토산글루코노델타락톤염및이염을이용하여올리고키토산을제조하는방법
GB0221941D0 (en) * 2002-09-20 2002-10-30 Univ Strathclyde Polysoaps
EP1440683A1 (de) * 2003-01-23 2004-07-28 Cognis France S.A. Verwendung von Oligoglucosaminen in kosmetischen oder dermatologischen Zubereitungen
US7390579B2 (en) 2003-11-25 2008-06-24 Magnequench, Inc. Coating formulation and application of organic passivation layer onto iron-based rare earth powders
JP5522615B2 (ja) * 2006-09-15 2014-06-18 国立大学法人 宮崎大学 貴金属イオン捕集剤として有用なポリマー
EP1955710A1 (en) * 2007-02-09 2008-08-13 The Jordanian Pharmaceutical Manufacturing Co. Aqueous composition comprising chitosan and an acidic drug
WO2008135957A2 (en) * 2007-05-07 2008-11-13 Koninklijke Philips Electronics N.V. A method for cleaning dental plaque from teeth using an adherent peelable gel
CA3186497A1 (en) * 2020-07-21 2022-01-27 Randell Clevenger Antimicrobial surfaces via multicomponent chitosan conjugates
WO2023003955A1 (en) 2021-07-20 2023-01-26 Molecular Surface Technologies, Llc Antimicrobial with modified-chitosan functionalization via dopamine linkage
KR20240147993A (ko) * 2022-02-03 2024-10-10 도소 가부시키가이샤 수용성 킬레이트 폴리머 및 그 제조 방법
JP2023115690A (ja) * 2022-02-08 2023-08-21 東ソー株式会社 キレートポリマー及びその製造方法
CN115724534A (zh) * 2022-09-07 2023-03-03 河北华电石家庄鹿华热电有限公司 一种三元阻垢缓蚀剂的制备方法及其应用
CN116813985B (zh) * 2023-07-14 2024-02-09 唐山学院 一种用于硫化氢气体的预警材料及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU419529A1 (cg-RX-API-DMAC10.html) * 1971-03-26 1974-03-15
US3879376A (en) * 1971-05-10 1975-04-22 Oreal Chitosan derivative, method of making the same and cosmetic composition containing the same
US3953608A (en) * 1971-05-10 1976-04-27 L'oreal Cosmetic compositions for the skin containing a chitosan derivative
DE3432227A1 (de) * 1984-09-01 1986-03-13 Wella Ag, 6100 Darmstadt Sulfopropylderivate des chitins und chitosans, verfahren zu ihrer herstellung sowie ihre verwendung

Also Published As

Publication number Publication date
DE59306229D1 (de) 1997-05-28
JPH0641202A (ja) 1994-02-15
EP0563013B1 (de) 1997-04-23
BR9301334A (pt) 1993-10-05
AU3551193A (en) 1993-09-30
AU658986B2 (en) 1995-05-04
EP0563013A2 (de) 1993-09-29
ATE152132T1 (de) 1997-05-15
EP0563013A3 (cg-RX-API-DMAC10.html) 1994-04-20
CA2092513A1 (en) 1993-09-28
KR100257092B1 (ko) 2000-08-01
KR930019700A (ko) 1993-10-18

Similar Documents

Publication Publication Date Title
AU3551193A (en) N-substituted chitosan derivatives, process for their preparation and the use thereof
CA2053253A1 (en) New aryl-and heteroarylethenylene derivatives and process for their preparation
PT97888A (pt) Processo para a preparacao de compostos heterociclicos derivados de indol e de composicoes farmaceuticas que os contem
IL102383A (en) Methylene-oxindole derivatives, their preparation and pharmacetutical compositions containing them
DK1026147T3 (da) Forbindelser, der er anvendelige som mellemprodukter i fremstillingen af piperidinderivater
CA2205757A1 (en) Pyridazinone derivatives and their use as inhibitors of prostaglandin g/h synthase i and ii(cox i and ii)
ES2075648T3 (es) Composicion para frenar la caida de los cabellos, y para inducir y estimular su crecimiento, a base de derivados de pirimidinas-n-oxido trisustituidas en las posiciones 2, 4 y 6 por una funcion amina, y nuevos compuestos de pirimidina-n-oxido.
CA2030519A1 (en) Acryloyl substituted pyrrole derivatives
ES8106291A1 (es) Procedimiento para preparar derivados de 3-aminoproxiarilo
CA2141969A1 (en) Cardio-Protective Agent
HK1047287A1 (zh) 喹啉和二氮杂萘羧酸抗菌剂
ES2093091T3 (es) Derivado de glutation.
CA2128093A1 (en) 4-Aryl-3-(Heteroarylureido)-1,2-Dihydro-2-Oxoquinoline Derivatives as Antihypercholesterolemic and Antiatherosclerotic Agents
DK0579295T3 (da) Detergentsammensætninger, som hæmmer farveoverførsel
ES2102327A1 (es) Nuevos derivados de 2,2,6,6-tetrametilpiperidina para utilizarse como agentes estabilizantes para materiales organicos contra la luz, el calor, y la oxidacion. n
UA43338C2 (uk) Похідні бензолу
PT96757A (pt) Processo de preparacao de derivados de indolo e de composicoes farmaceuticas
CS302790A3 (en) Functional derivatives of 4-(2,4-difluorobiphenylyl)-2-methyl -4- oxobutanoic acid
PT83920B (pt) Processo para a preparacao de novos derivados de 4-morfolini-1h-indol e dos seus sais e de composicoes farmaceuticas que os contem
FI933468A0 (fi) Tetrahydronaftalenderivat, framstaellning av dessa och terapeutisk anvaendning av dessa
DE69204480D1 (de) Anilinderivate und Verfahren zu ihrer Herstellung.
CA2052020A1 (en) Pradimicin derivatives
IL136659A0 (en) Novel antiarrythmic compounds
SE7813351L (sv) Substituerade 1,5-cyklohexadien-karboxylsyraderivat
IE44999L (en) Hydrazinopyridazine derivatives.

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees